• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Michael Friis

Head of Equities

Michael Friis portrait

Coverage

HydractAudientesRealfictionShape RoboticsScape TechnologiesGreenMobilityCurasightOrderYOYOPenneoPhotocatOdicoAgillicBawat Water TechnologiesImperoMapsPeopleNNITNordic SolarScandinavian Medical SolutionsWindowMaster InternationalGomSpaceCABA CapitalAscelia PharmaEmbla MedicalBioPortoGubraExpreS2ion Biotech

Latest content

ShowingAll content types

Ascelia Pharma: CRL reshapes the investment case materially, key questions remain open

Analyst Comment 03.07.2026, 16.11 by Michael Friis
Ascelia Pharma

B&O: Præsentation af FY 2025/26-resultater (Optagelse)

Analyst Comment 03.07.2026, 12.05 by Michael Friis
Bang & Olufsen

Dagens aktienyheder 03/07/2026: B&O, NORDEN, Ascelia Pharma og Wirtek

Analyst Comment 03.07.2026, 08.53 by Michael Friis, Rasmus Køjborg
Ascelia PharmaBang & OlufsenWirtekD/S Norden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

B&O: CEO-interview i forbindelse med FY 2025/26

Video 03.07.2026, 08.40 by Michael Friis
Bang & Olufsen

HCA Morgenbørs 02/07 - Udsalg i AI infrastruktur

Video 02.07.2026, 09.27 by Michael Friis, Victor Skriver
Bang & OlufsenNKTNovo NordiskPandora

B&O: Sell-out accelererer, 2026/27 guidance indikerer en begyndende vending

Analyst Comment 02.07.2026, 08.45 by Michael Friis
Bang & Olufsen

Dagens aktienyheder 01/07/2026: GomSpace, WindowsMaster og GrønlandsBANKEN

Analyst Comment 01.07.2026, 08.51 by Michael Friis, Rasmus Køjborg, Victor Skriver
GomSpaceWindowMaster InternationalGrønlandsbanken

HCA Morgenbørs 30/06 - Udsigt til små kursstigninger i Europa

Video 30.06.2026, 10.19 by Michael Friis, Rasmus Køjborg
A.P. Møller - MærskBooztVestas Wind SystemsNovo Nordisk

Dagens aktienyheder 30/06/2026: Flügger, Hafnia og danske rumaktier

Analyst Comment 30.06.2026, 08.51 by Rasmus Køjborg, Michael Friis
Flügger GroupHafniaGomSpaceRovsing

HCA Morgenbørs 29/06 - Udsigt til kursstigninger og fokus på sektorrotation

Video 29.06.2026, 09.16 by Michael Friis, Rasmus Køjborg
Flügger GroupLundbeckCarlsbergBavarian Nordic